Results of the landmark MIROCALS clinical trial, involving researchers from the University of Sheffield, have revealed new ...

Results of the landmark MIROCALS clinical trial, published in The Lancet, show a low-dose interleukin-2 (IL2LD) is safe, ...

Amnic, a leading cloud cost observability platform, today unveiled Amnic AI, a FinOps OS powered by AI agents, and built on Amazon Web Services (AWS). Amnic AI functions as an operating layer and ...

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published in The Lancet.

Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity ... a SaaS company that helped define the current digital identity landscape and is now part of GB Group plc. "Building on Mitek ...

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published in The Lancet. This is ...

Icon PLC (NASDAQ:ICLR) reported better-than-expected adjusted EBITDA margin performance of 19.5% for Q1 2025, demonstrating effective cost control and resource alignment. The company has seen a ...

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported first-quarter earnings of $154.2 million. The Dublin 18, Ireland-based company said it had profit of $1.90 per share. Earnings, adjusted ...

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported first-quarter earnings of $154.2 million. The Dublin 18, Ireland-based company said it had profit of $1.90 per share. Earnings ...